Walleye Capital’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$821K Sell
12,700
-1,300
-9% -$91.6K ﹤0.01% 2255
2025
Q4
$942K Buy
14,000
+8,700
+164% +$585K ﹤0.01% 2483
2025
Q3
$389K Sell
5,300
-400
-7% -$26.6K ﹤0.01% 2810
2025
Q2
$297K Buy
5,700
+1,600
+39% +$91K ﹤0.01% 3060
2025
Q1
$262K Buy
+4,100
New +$238K ﹤0.01% 3059
2024
Q4
Sell
-4,200
Closed -$240K 5120
2024
Q3
$240K Buy
4,200
+1,300
+45% +$74.5K ﹤0.01% 3863
2024
Q2
$152K Sell
2,900
-6,700
-70% -$294K ﹤0.01% 4484
2024
Q1
$391K Buy
9,600
+7,800
+433% +$292K ﹤0.01% 3419
2023
Q4
$66.5K Sell
1,800
-1,600
-47% -$60.3K ﹤0.01% 4217
2023
Q3
$130K Buy
+3,400
New +$139K ﹤0.01% 3806
2023
Q1
Sell
-200
Closed -$11.4K 4109
2022
Q4
$11.4K Sell
200
-200
-50% -$10.2K ﹤0.01% 2740
2022
Q3
$16K Buy
+400
New +$17.7K ﹤0.01% 2755
2019
Q4
Sell
-200
Closed -$3K 1979
2019
Q3
$3K Sell
200
-13,400
-99% -$221K ﹤0.01% 1824
2019
Q2
$234K Buy
+13,600
New +$219K 0.03% 880

Other funds holding HALO

Walleye Capital's HALO Position: Q1 2026 in Review

Walleye Capital increased its Halozyme (HALO) stake by 19% in Q1 2026, buying an estimated $613K and bringing the position to 53,364 shares worth $3.45M. The position accounts for 0.01% of the portfolio, ranked #1043.

Walleye Capital first reported a position in HALO in Q2 2019 and has held it in 14 quarters since. The position peaked at $9.81M in Q2 2024. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Walleye Capital held 53,364 shares of Halozyme worth $3.45M as of Q1 2026.
  • Walleye Capital bought 8,696 Halozyme shares in Q1 2026, an estimated $613K.
  • Halozyme made up 0.01% of Walleye Capital's portfolio in Q1 2026, its #1043 holding.
  • Walleye Capital first reported a position in Halozyme in Q2 2019 and has held it in 14 quarters since.
  • Walleye Capital's Halozyme position peaked at $9.81M in Q2 2024.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.